You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 35 No. 8, August 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (86)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Abrupt Withdrawal From Therapeutically Administered Diazepam

Report of a Case

Jeffrey S. Pevnick, MD; Donald R. Jasinski, MD; Charles A. Haertzen, PhD

Arch Gen Psychiatry. 1978;35(8):995-998.


Abstract

• Subjective, behavioral, and physiologic changes followed abrupt withdrawal of diazepam (Valium) in a patient who had been treated with 30 to 45 mg of diazepam daily for 20 months. Precipitous weight loss and orthostatic pulse rate increase were a part of the abstinence syndrome, which occurred between the fifth and ninth days of withdrawal. Accompanying these changes in physiologic measures were discomforting symptoms and dysphoria that were aversive and reinforcing to drug taking since the patient sought diazepam administration. These observations suggest that changes in mood, feeling states, and behavior may be the most prominent characteristics of the abstinence syndrome associated with physical dependence on this dose level of diazepam.



Author Affiliations

From the National Institute on Drug Abuse, Division of Research, Addiction Research Center, Lexington, Ky. Dr Pevnick is now with the Missouri Institute of Psychiatry, St Louis.


Footnotes

Accepted for publication March 7, 1977.

Reprint requests to National Institute on Drug Abuse, Division of Research, Addiction Research Center, PO Box 12390, Lexington, KY 40583 (Dr Jasinski).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Flumazenil Provocation of Panic Attacks: Evidence for Altered Benzodiazepine Receptor Sensitivity in Panic Disorder
Nutt et al.
Arch Gen Psychiatry 1990;47:917-925.
ABSTRACT  

Alprazolam Augmentation of the Antipsychotic Effects of Fluphenazine in Schizophrenic Patients: Preliminary Results
Wolkowitz et al.
Arch Gen Psychiatry 1988;45:664-671.
ABSTRACT  

Withdrawal After Substitution of a Short-Acting for a Long-Acting Benzodiazepine
Conell and Berlin
JAMA 1983;250:2838-2840.
ABSTRACT  

Withdrawal Reaction From Long-term, Low-dosage Administration of Diazepam: A Double-blind, Placebo-Controlled Case Study
Winokur et al.
Arch Gen Psychiatry 1980;37:101-105.
ABSTRACT  

Acute Toxic and Withdrawal Reactions Associated with Drug Use and Abuse
KHANTZIAN and McKENNA
ANN INTERN MED 1979;90:361-372.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.